Mobile terms and conditions
Prolia® injection reminder
text message program
Once enrolled in the Prolia® Patient Support Program, Prolia® patients can sign up for helpful injection appointment reminders. These reminders can be delivered through direct mail or via a phone call. Patients can choose to receive their phone call reminders from a live agent, automated voice message or through text message.
Important Program Information: This program is intended for the limited purpose of delivering courtesy reminder notifications to remind you to schedule your next injection of Prolia®. However, it is up to you and/or your caregiver to ensure you obtain your next injection in a timely manner and in accordance with your doctor’s instruction. This program is not intended to be a source of medical advice or treatment and does not replace in any way independent medical advice regarding your diagnosis or treatment. Any questions about medications or health care should be presented to your doctor.
As a reminder, you must be 18 years old to participate. By participating, you agree that you are solely responsible for determining whether the use of this program is right for you, and you agree to release Amgen from any liability relating to your use of this program.
Enrollment and getting started:
At this time, enrollment for the Prolia® injection appointment reminder program can be completed online at Prolia.com or with one of our live agents at 855-618-4502.
Within the Prolia® Patient Support Program registration section on Prolia.com, specific to the text message option, patients will be asked to provide the following information:
At the time of registration, patients can also view the Mobile Terms and Conditions, which is also included on this page.
Once a patient enrolls in the Prolia® Patient Support Program and chooses to receive injection appointment reminders via SMS/text message reminders, patients will receive a welcome text message from 63280 confirming their desire to enroll in the Prolia® injection reminder text program. The patient will need to reply 'YES' to confirm enrollment. Should the patient not confirm enrollment, they will not be enrolled in receiving injection appointment text reminders for Prolia®. See below for message example:
Injection appointment text reminders will be sent based on the injection appointment date provided during enrollment. For example:
Patient provides next injection date of December 1 = First injection appointment reminder text will be sent to you on November 19, 14 days before their next appointment date, and a second reminder will be sent on November 26, 7 days before their next appointment date. A post-appointment confirmation message will be sent on December 6, 5 days post their appointment date.
How many text messages will patients receive?
The amount of injection appointment text reminders received by the patient will vary per month based on their registration preference. On average, a patient may receive 1 message every two months during most months, and approx. 3-5 messages in the month of their appointment date (which will happen twice per year).
A patient can opt out of the Prolia® injection appointment reminder program at any time by calling 1-855-618-4502.
Should the patient have any questions about Prolia® or the Prolia® Patient Support Program please do not reply to any text message sent to you through the injection appointment reminder program, as responses are not monitored. Instead, please call 1-855-618-4502 and a helpful representative can help assist you.
Amgen's Prolia® Reminders mobile Short Message Service (SMS) program runs on the short code 63280. Amgen will not charge you to use this Service; however your Wireless Service Provider may charge for sending and/or receiving messages and for air-time.
Visit Prolia.com or call 1-855-618-4502 to subscribe to Prolia® SMS injection appointment reminders. You will receive recurring messages. Text HELP to 63280 for help, STOP to 63280 to cancel. Message and Data Rates May Apply.
TO OPT-IN TO PROLIA® REMINDERS OR RECEIVE SUBSCRIPTION MESSAGES:
Visit Prolia.com or call 1-855-618-4502 to enroll. Provide the required information including your mobile phone number. You will receive an opt-in request from 63280 to your mobile phone number. Follow the texting prompts to complete your subscription.
EXAMPLE RESPONSE FROM 63280:
Prolia(R) (denosumab): You will get recurring text message reminders to schedule your injection appts. based on the date you provided when you signed up.
TO STOP (OPT-OUT OF) THE SERVICE ON 63280:
You can cancel receipt of all SMS messages from 63280 by replying to any Service message, or sending 'STOP', 'END', 'QUIT', 'UNSUBSCRIBE', or 'CANCEL' to 63280.
EXAMPLE STOP MESSAGE:
Prolia(R) (denosumab): You'll no longer receive text msgs from this reminder program or 63280. To re-enroll visit Prolia.com or call 855-618-4502.
TO GET HELP ON THE SERVICE ON 63280:
You can get HELP, by replying to any Service message, or sending 'HELP' to 63280. You can also call 1-855-618-4502 for more information.
EXAMPLE HELP MESSAGE:
Prolia(R) (denosumab): For questions on the Prolia(R) injection reminder program or to update your injection appointment date call 855-618-4502.
What are the possible side effects of Prolia®?
It is not known if the use of Prolia® over a long period of time may cause slow healing of broken bones. The most common side effects of Prolia® in women being treated for osteoporosis after menopause are back pain, pain in your arms and legs, high cholesterol, muscle pain, and bladder infection.
The most common side effects of Prolia® in men with osteoporosis are back pain, joint pain, and common cold (runny nose or sore throat).
The most common side effects of Prolia® in patients with corticosteroid-induced osteoporosis are back pain, high blood pressure, lung infection (bronchitis), and headache.
The most common side effects of Prolia® in patients receiving certain treatments for prostate or breast cancer are joint pain, back pain, pain in your arms and legs, and muscle pain. Additionally, in Prolia®-treated men with nonmetastatic prostate cancer receiving ADT, a greater incidence of cataracts was observed.
These are not all the possible side effects of Prolia®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Prolia® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.
Prolia® is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture.
Prolia® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture.
Prolia® is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
Prolia® is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.